Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

AML patient raises awareness in community about national stem cell registry

AML patient raises awareness in community about national stem cell registry

Researchers identify cell of origin for sarcoma

Researchers identify cell of origin for sarcoma

Researchers use computers to capture chemical signal structure that triggers metastatic cancer

Researchers use computers to capture chemical signal structure that triggers metastatic cancer

Cord Blood America purchases minority interest in Stem Cells VIDAPLUS

Cord Blood America purchases minority interest in Stem Cells VIDAPLUS

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

More research needed to determine link between folic acid and breast cancer

More research needed to determine link between folic acid and breast cancer

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

First patient treated in cytomegalovirus~ACE/ASPECT Phase II randomised clinical trial

bcl3 gene limits lung injury during acute stress from illness, trauma, transplant

bcl3 gene limits lung injury during acute stress from illness, trauma, transplant

CytRx's bafetinib helps reduce skeletal complications in cancer patients

CytRx's bafetinib helps reduce skeletal complications in cancer patients

Study estimates 1.3 million cancer deaths in Europe in 2011

Study estimates 1.3 million cancer deaths in Europe in 2011

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

EpiCept enters definitive agreements to purchase 8.9 million shares of common stock

Munich research team provides promising alternative to DNA-based procedures

Munich research team provides promising alternative to DNA-based procedures

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Positive results from EpiCept NP-1 Phase IIb trial in patients with CPN

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

Genomic study identifies link between Native American ancestry, relapse in young leukemia patients

Immunomedics reports net loss of $3.4M in total revenues for second quarter 2011

Immunomedics reports net loss of $3.4M in total revenues for second quarter 2011

Lack of DOT1L enzyme could lead to some types of heart disease: Study

Lack of DOT1L enzyme could lead to some types of heart disease: Study

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

EntreMed announces publication of ENMD-2076 Phase 1 results against solid tumors in AACR journal

Cord Blood America signs second Supply Agreement with premier cell and tissue bank

Cord Blood America signs second Supply Agreement with premier cell and tissue bank

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

Scientists reprogram marrow cells from patient with chronic myeloid leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.